← All trials
NCT07277322
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 15, 2025
- Primary completion
- Dec 16, 2030
- Completion date
- Dec 16, 2030
- First posted
- Dec 11, 2025
- Last posted
- Dec 11, 2025
- Enrollment
- 24
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Icahn School of Medicine at Mount SinaiLead sponsor
- Coherus Oncology, Inc.Collaborator
- Icahn School of Medicine at Mount SinaiOfficial
- Icahn School of Medicine at Mount SinaiSponsor investigator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.